Lombardi Comprehensive Cancer Center

06/01/2026

Georgetown joins the nation in celebrating Pride Month, honoring the legacies, accomplishments and contributions of our LGBTQIA+ community. https://bit.ly/4v6EpYE

05/29/2026

05/28/2026

At Lombardi Comprehensive Cancer Center, groundbreaking cancer research is powered by collaboration, innovation and a commitment to caring for the whole person. From breast cancer and hereditary cancer research to biomedical informatics and cancer aging studies, Georgetown Lombardi’s research centers are advancing discoveries that shape the future of prevention, treatment and survivorship. Learn more about our Research Centers and how their work is transforming lives across our communities: https://lombardi.georgetown.edu/research/centers/

The Nina Hyde Center for Breast Cancer Research, established in 1989 as a tribute to a former fashion editor of The Washington Post, uses a collaborative, multidisciplinary approach to conduct cutting-edge breast cancer research.

05/25/2026

On this , we honor all our fallen service members. We are grateful for their sacrifice and for the families who carry their legacy forward.

05/22/2026

05/21/2026

At Lombardi Comprehensive Cancer Center, cancer care goes beyond treatment. Guided by the value of cura personalis, or care of the whole person, healing includes innovative therapies, as well as therapeutic art, emotional support, and resources that care for patients and their families throughout every step of the journey. Learn about Georgetown Lombardi’s patient and family resources: https://lombardi.georgetown.edu/patient/patient-family-resources/

Arts & Humanities Program The Georgetown Lombardi Comprehensive Cancer Center Arts & Humanities Program promotes an optimum life experience for patients, family members, and caregivers with activities, resources, education and environments that encourage a creative and constructive response to illn...

05/18/2026

Researchers at Georgetown’s Lombardi Comprehensive Cancer Center have identified a mechanism that may help explain a key reason why older people experience worse outcomes from breast cancer. The study implicates RAGE (Receptor for Advanced Glycation End-products), a cell surface receptor that amplifies inflammatory signaling, and which also becomes increasingly active with metastatic progression. “Our study addresses a major gap by showing that aging dramatically increases breast cancer metastasis, and that this effect depends on RAGE, a receptor on the surface of cells that fuels inflammation,” says Barry Hudson, PhD, associate professor of oncology at Georgetown Lombardi and corresponding author for this article. The finding appeared in the Nature journal Communications Biology. Learn more: https://lombardi.georgetown.edu/news-release/study-reveals-why-breast-cancer-becomes-more-deadly-with-age/

Researchers at Georgetown Lombardi have identified a mechanism that may help explain why older people experience worse outcomes from breast cancer.

05/14/2026

Exciting programming announcement for the Lombardi Men’s Event incoming! 🏈 🏟️

London Fletcher, analyst and legendary linebacker, and Andy VanHorn, Commanders Head of Real Estate, will sit down with Andy Pollin for an insider’s talk on the new stadium and what legacy means to this franchise and its fans. 

Join our Fireside Chat—tickets are still available but not for long! Secure your spot at 🔗 in bio

https://lombardimen.georgetown.edu/fireside-chat/

05/11/2026

Gear Up, End Cancer! Join Team Ruesch for this year's
BellRinger - October 23-24th, 2026! 🚴‍♂️ Choose to ride 25, 50, 62, or 100 miles and join a community of people passionate in their pursuit to end cancer. With over $6.6 million raised and counting for groundbreaking research at Lombardi Comprehensive Cancer Center, our work has never been more important. Support Team Ruesch: https://ride.bellringer.org/team/teamruesch34

05/11/2026

During , we want to thank our amazing nursing team at Lombardi Comprehensive Cancer Center /MedStar Georgetown University Hospital for their dedication to patient care. Thank you, April Stafford, RN; Bobbie Jo Khan, MS, RN, OCN, and Junga Kim, RN.